ARCHIVES

CMS Issues Coverage Decision For Provenge in Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

Former NCI Lab Deputy Charged With Two Criminal Counts

January 17, 1992

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

September 30, 2005

NCCS Networker Volume 2 Issue 1, Winter 1988

January 13, 1988

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994